Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Order #846273
On February 27 when Cronos listed on the NASDAQ it did 2.8 million and then the next day 9.88 million the next day 11.86 million
I say we do 5 million
letting it ride for at least a year
Order #836744
Order #833213
My wife loves her Foria
NDP URGES MORNEAU TO END EXCISE TAX
ON MEDICAL CANNABIS
OTTAWA – NDP Finance Critic Peter Julian, MP (New Westminster-Burnaby), has urged Finance Minister Bill Morneau to eliminate a significant increase in prescription medical cannabis costs by stopping the implementation of a new excise tax on medical cannabis. Finance Canada officials confirmed the increase before the Finance Committee yesterday.
“We believe that the Liberals’ medicinal cannabis tax policy is misconceived, unfair to patients, and damaging to public health. Why wasn’t this tax exempted from the budget implementation act?” asked Julian. “The cost of this prescription medicine is already an obstacle for the over 250,000 authorized cannabis patients. Government should be helping patients ease their financial burden. Unless this government steps in, this excise duty tax could very well push many Canadians and their families into a health crisis, at a time when the need for a universal pharmacare program in our country has never been greater.”
Julian has written to Morneau calling on the Finance Minister to do the right thing by medical cannabis patients, zero-rate medical cannabis tax in line with all other prescription medicine and to exempt medical cannabis from any additional taxes by amending T 3 Amendments to the Excise Act, 2001 (Cannabis Taxation), the Excise Tax Act and Other Related Texts, 69(4) Section 2 of the Act, to support amendments to Bill C-74 in the Standing Committee on Finance to remove this particular new excise tax you had proposed on patients who have prescriptions for medical cannabis.
“Canadians that have a prescription for medical cannabis are currently forced to spend hundreds or thousands of dollars every month to acquire a sufficient amount of medicine, or choose a riskier option, like a prescription opioid, because it’s tax exempt and covered for reimbursement,” said NDP Health Critic Don Davies, MP (Vancouver Kingsway). “This is perverse, and even more illogical given the growing body of data which suggests that cannabis can play a significant role in addressing the opioid crisis.”
Julian has put forward an amendment to Bill C-74, the Budget Implementation Act to end the excise tax on medical cannabis. The Finance Committee will vote on the amendment next month.
-30-
For more information, please contact Ms. Mounia Lahbabi at 613.992.4214 peter.julian@parl.gc.ca
Order #818154
NEW: Tell the Finance Committee to Drop Proposed Sin Tax
http://donttaxmedicine.ca/NoTax/budget/
Not that I heard
Hap Sneddon discusses Aurora Cannabis
Hap Sneddon, chief portfolio manager and founder at Castlemoore Inc., discusses Aurora Cannabis.
WAIT FOR IT
https://www.bnnbloomberg.ca/video/hap-sneddon-discusses-aurora-cannabis~1383095
Canopy Growth CEO Bruce Linton: Won't be stretched too thin by pursuing global ambitions
BNN Bloomberg speaks with Canopy Growth CEO Bruce Linton about how the company is positioning to integrate numerous businesses under the same banner, how global assets are being integrated, and how the company is getting ready for the legalization of recreational marijuana.
https://www.bnnbloomberg.ca/video/canopy-growth-ceo-bruce-linton-won-t-be-stretched-too-thin-by-pursuing-global-ambitions~1383022
An awakening': Major Canadian pension funds wade into pot stocks
https://www.bnnbloomberg.ca/an-awakening-major-canadian-pension-funds-wade-into-pot-stocks-1.1068118
CNN weed 4 pot vs pills CNN SPECIAL REPORT 4/29/18
Tweed: What Hundreds of Thousands of Dollars Worth of Weed Looks Like
A friend of mine received this email today.
Dear valued patients,
The time has come for us to close up shop. The unfortunate decision has been passed down from the Crown to the local OPP detachment that we are no longer able to operate in Collingwood.
We are sending out this email as a heads up that we will only be open for Tuesday (24th) and Wednesday (25th) from 12PM-630PM of this week and then will be forced to shut down.
We truly appreciate all our customers and are sad things had to go this way, but we are still glad we had a chance to help and meet everyone.
Thanks everyone!
Two Trees - Kait & Mark https://www.twotreesmd.ca
https://www.theglobeandmail.com/globe-investor/personal-finance/what-happens-to-your-retirement-savings-in-a-divorce/article567142/
"Registered retirement savings plans (RRSPs) and registered retirement income funds (RRIFs) as well as pensions are considered family property to be divided 50-50 in a legal separation or divorce. The Income Tax Act provides for tax-free rollovers of RRSPs and RRIFs between spouses where there is a court order or written separation agreement, which allows for the equalization of registered assets without significant tax implications.
"
https://www.canada.ca/en/revenue-agency/services/forms-publications/forms/t2220.html
http://www.advisor.ca/tax/tax-news/minimize-tax-on-marriage-breakdown-104725
RRSP and RRIF transfers
If some or all of the amounts in an RRSP or RRIF are being transferred between spouses or common-law partners as a result of separation or divorce, the transfer can take place on a tax-deferred basis on two conditions:
•the money being transferred remains in a RRSP or RRIF of the recipient spouse or partner, and
•the transfer is done pursuant to a court order or written separation agreement using CRA form T2220.
When the recipient spouse or common-law partner later withdraws money from his or her RRSP or RRIF, the full amount is taxable in that person’s hands at their marginal tax rate in the year of withdrawal.
So, in some cases it makes sense to transfer some or all of an RRSP or RRIF as part of equalization between spouses on relationship breakdown.
Specifically, RRSP transfers are a preferable way of satisfying equalizing obligations when there is a dramatic difference between the marginal tax rates of the spouses, particularly where the recipient spouse intends to draw income from the RRSP or RRIF at a future time when his or her taxable income is lower.
I really thought I was done buying… But I never thought I would have the opportunity to buy at these levels
Here’s to future growth
Order #779146
https://www.ctvnews.ca/business/flying-high-100-000-pot-plants-flown-from-ontario-to-b-c-1.3808316
Under tight security, 100,000 marijuana plants arrived at Vancouver International Airport Saturday to be cultivated in a network of greenhouses in Langley, B.C. that’s being touted as the largest licensed cannabis production facility in the world.
That Metro Vancouver facility is run by BC Tweed Joint Venture Inc., which involves a B.C. greenhouse operator and cannabis giant Canopy Growth Corp., whose marijuana production licence was just approved on Feb. 16.
Although recreational pot will likely not be commercially available in Canada until August at the earliest, companies like BC Tweed are already gearing up for legalization.
Cannabis plants are wheeled into a marijuana production facility in Langley, B.C. on Feb. 17, 2018. (CTV Vancouver)
BC Tweed
A view inside a network of greenhouses in Langley, B.C. that’s being touted as the largest licensed cannabis production facility in the world. (CTV Vancouver)
BC Tweed
Workers unload supplies at BC Tweed's sprawling Langley, B.C. cannabis production facility on Feb. 17, 2018. (CTV Vancouver)
“We have five distribution deals with the provinces that have announced (their legalization plans) so far in Canada,” Canopy Growth spokesperson Jordan Sinclair told CTV Vancouver on Saturday. “So we'll be using this for recreational sales as well as medical sales.”
The plants were loaded up in Canopy Growth’s sprawling Smith Falls, Ont. facility and flown from nearby Ottawa to Vancouver. They were transported to Langley in armoured vehicles.
The greenhouses where they will be cultivated were formerly used to grow bell peppers.
“It’s quite a change from vegetable production,” BC Tweed’s Victor Krahn said.
At 1.3 million square feet, or 30 acres, the Langley facility is massive. It has room to house roughly 350,000 marijuana plants and will produce tens of thousands of kilograms of dried cannabis per year.
“The clones will be transplanted into little pots of soil and then they’ll grow under the lights for a number of months and then they’ll be ready to harvest,” Sinclair said of the cultivation process.
“We have lights and blackout shades, so it's the technology meets Mother Nature and gives us the perfect environment,” Krahn added.
There are strict guidelines for growing cannabis, including steps to make sure no contaminants enter the facility, as well stringent security measures.
“There's fences and only a couple entry points, cameras everywhere,” Sinclair said. “Also, the site itself is difficult to access: once you get in, you need swipe cards and biometric information.”
Sinclair says that neighbours won’t have to worry about pungent pot odours either.
“We have controls in place to control the amount of smell,” he added. “There shouldn't be any issues with smell.”
The facility’s first harvest is expected in late spring. A second BC Tweed site in nearby Delta, B.C. with even more greenhouses will begin growing pot later this year.
just emptied my dry powder. Thank you who ever sold at 32.00
the market knew it was my bd... WHAT A DAY
Order #735176
Canopy And Aurora: Who Just Had The Better Quarter?
Feb. 23, 2018 9:48 AM ET|13 comments| About: Aurora Cannabis Inc. (ACBFF), TWMJF, Includes: CMMDF, LQSIF, VRNDF
Cornerstone Investments
Cornerstone Investments
Long only, special situations, medium-term horizon
(4,281 followers)
Summary
Canopy announced lower cash cost, higher production, and strong build in inventory which supported its recent supply deal wins.
Aurora remains a show-me story with significant execution risk.
Canopy so far has executed better in preparation for the upcoming legalization but Aurora has potential to catch in B.C. and Alberta.
The rivalry between Canopy (OTCPK:TWMJF) and Aurora (OTCQX:ACBFF) has only intensified in recent months as Aurora is set to surpass Canopy as the largest cannabis company in the world after announcing its acquisition of CanniMed (OTC:CMMDF). We have written in "Is Canopy Falling Behind Aurora?" that we think Canopy has been focusing on perfecting execution and preparing for the upcoming legalization while Aurora has embarked on an acquisition spree that saw its investments spanning from greenhouse contractor to liquor stores. Both companies have reported their latest quarter, and we think it is time to have a comparison of who had the better quarter!
Canopy Highlights
Canopy reported Q3 F2018 results that saw several positive developments. The patient counts increased 138% to 69k, another 10% increase on a sequential basis. Canopy boasts the largest active registered patients' base in the market and also the largest current production. Canopy achieved a significant reduction in production costs and saw its cost per gram dropping to $1.03 per gram in the quarter. Canopy harvested almost 8 million kilograms while sales were 2.3 million kilograms. Revenue came in at $21.7 million, up 23% sequentially and 123% year over year. The average selling price was $8.30 per gram, a 13% increase from last year. Lastly, Canopy had $238 million of cash on hands at the end of the quarter, before accounting for the net proceeds of $192.5 million from recently completed bought deal financing.
(Canopy Financial Statements)
Aurora Highlights
Aurora also reported a strong quarter. Revenue increased by 42% to $11.7 million sequentially. Actively registered patient count grew 12.6% to almost 22k. Total grams sold increased 31% sequentially to 1.1 million grams and represent 116% increase from last year. Grams produced was close to the grams sold at 1.2 million gram. Average selling price increased to $8.36 representing a 1.7% increase sequentially and 40% increase over last year. Cash cost per gram decreased by 25% sequentially to $1.41. At the end of the quarter, Aurora held cash balance of $350 million, before investment of Liquor Stores (OTCPK:LQSIF) and CanniMed acquisition (cash portion of the consideration to be determined).
(Aurora Financial Statements)
Comparison #1 Production Costs
As we discussed at length in The Complete Cannabis Guide #1: Production Cost that production costs will become a key competitive advantage for producers once legalization happens. The influx of LPs and numerous expansions announced by existing producers will most likely result in the market oversupplied. In an oversupplied market, prices will be pressured and only producers on the low end of the cost curve will be able to survive. Canopy has already established the largest scale in the industry and is moving down the cost curve at a fast pace. Canopy's cost per gram before fulfilling dropped 18% in the latest quarter from $1.25 to $1.03, approaching some of the lowest costs we have seen in the industry. Aurora, in the meantime, dropped from $1.87 to $1.41, still much higher than the industry averages. Canopy is clearly winning in this metric at the moment. We acknowledge that Aurora Sky is supposed to deliver some of the best cash costs for Aurora in the coming quarters, but execution risks remain a valid concern given its lack of track record in large-scale production.
(Tutor2U)
Comparison #2 Production and Inventory
Canopy has absolutely blown us away this quarter with its production and inventory build up. As we have reiterated in our "5 Predictions For The Cannabis Industry", we think the key thing to watch for 2018 is the supply agreements. One of the key requirement for supply agreements is a company's ability to deliver high-quality cannabis with reliability. The Canadian Senate has announced that cannabis legalization won't happen before August 2018, leaving at least three more quarters for companies to fill up inventory in preparation for a consumer frenzy in the initial few months.
This past quarter, Canopy increased its production by 91% to almost 8 million grams. With sales of 2.3 million grams, Canopy was able to build up inventory significantly and will continue to do so in the coming quarters. Canopy reported inventory and biological assets valued at a record $108 million by the end of the quarter. Aurora showed a very different picture as production barely covered sales, which means little to none has been saved for inventory. Aurora has also reported a smaller inventory of $17 million, basically unchanged from last quarter.
Usually, an inventory build could be a result of bad working capital management or falling sales. In this case, as the cannabis industry is ripe for legalization later this year, there will be an initial surge in demand as consumers chase novelty. We expect the industry to be undersupplied initially as many producers are still in the process of constructing their facilities, not to mention start producing cannabis and building up an inventory. We like Canopy's large inventory position because it will be crucial for the company to win provincial deals. For companies that do not have any inventory in hand, it would be tough to convince provinces that they could become a reliable supplier in the near-term, as there are risks inherent in cultivation and harvesting. In the case of Aurora, the company's production is only enough to satisfy its current sales, which means that there won't be any room for the recreational market when it becomes legalized. The difference between the cannabis industry and others is that a much bigger market will open up this year and demand will increase multifold, placing a big emphasis on producers to ramp up production and have inventory on hand to stock the shelves.
(legalcannabis.com)
Comparison #3 Provincial Deals
Another point we want to bring up is the results from recently announced Quebec and Manitoba deals. In the Quebec deal, as we recently wrote in "Canopy Clinched Quebec Victory" that Canopy has secured a larger deal of 12,000 kg annually versus Aurora's 5,000 kg annually. We don't blindly take the headline number as little details were provided by the six companies that secured a deal and actual sales numbers could vary depending on final delivery. There was also little details regarding the terms of the deals. However, last week, Canopy also announced that its partnership with Delta 9 (OTC:VRNDF) was selected as one of the four groups to operate retail licenses for the provincial cannabis sales. Aurora was nowhere to be found in the deal. It is worth noting that Aphria (OTCQB:APHQF) also secured one of the retail licenses through its investment in Hiku/Tokyo Smoke, another group that was selected. If you add Canopy's previously announced supply deal with New Brunswick, Newfoundland and Labrador, and Prince Edward Island it becomes clear that Aurora is quickly falling behind Canopy as its limited scale is hurting its execution.
If you look at the map below, the only large provinces that have yet to announce a supply deal are Ontario, British Columbia, and Alberta. We think Canopy is better positioned in Ontario due to its dominant position in the province. Canopy is also building out its British Columbia through its 67% owned joint venture, BC Tweed. Canopy has already started expanding crazily in B.C. as it was reported that its 1.3 million sq. ft. Langley facility will start harvesting in Spring 2018, with a second facility planned in Delta, B.C. for later this year. Aurora is building its largest Aurora Sky facility in Edmonton, Alberta and is in the process of acquiring CanniMed which is based in Saskatchewan. Aurora also announced its investment in Liquor Stores and we have written about the deal in details in "Why Aurora Cannabis Invested Into Liquor Stores" where we concluded that Aurora is indeed doubling down on the Alberta market. Alberta has the fourth largest population after Ontario, Quebec, and British Columbia but by itself alone cannot support Aurora's current market capitalization. Aurora needs to score big in the upcoming supply agreements, especially Ontario and British Columbia.
https://static.seekingalpha.com/uploads/2018/1/20/24621363-1516430235035653.png
(Government of Canada)
Summary
As we wrote in our recent article "Is Canopy Falling Behind Aurora?", we think the execution risk of Aurora remains high as it lacks the scale to secure the first wave of supply agreements and its future growth hinges on the timely and flawless delivery of Aurora Sky. We have long been praising the focus and execution of Canopy management, and they have delivered another promising quarter with rising inventory, lower cash cost, and increasing cannabis productions. Aurora also had a good quarter with rising sales, higher patient counts, and a good update on its upcoming facilities and international expansions. However, we would like to see Aurora focus more on the domestic recreational market as it will become the single largest and most important market for all cannabis companies. International markets represent long-term opportunities but near-term contribution will remain limited and these countries could be years away from legalizing recreational cannabis.
Additional Resources
We publish on cannabis-related topics regularly. Consider "follow us" to stay informed of the latest development and best ideas in the sector. We also publish a widely read Weekly Cannabis Report which is your best way to receive our weekly review and analysis of the cannabis sector.
You can also find our previous articles on the cannabis industry:
Is Canopy Falling Behind Aurora?
Best Way To Play The Cannabis Industry
5 Predictions For the Cannabis Industry
The Complete Cannabis Guide #1 - Production Cost
The Complete Cannabis Guide #2 - Production Capacity
The Complete Cannabis Guide #3 - Consumption
Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Editor's Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks.
Order #721244
Good thing the way our founder dresses has NO effect on share price...have you seen how Facebook founder Mark Zuckerberg dresses?? Seems to work for Mark at market cap of 520 billion
We are not #1 in Germany
Aurora Announces Q2 Fiscal 2018 Results Strong Patient and Revenue Growth
-Dried cannabis sold in Germany
$2.5 million, up 101.1% sequentially;
http://marijuanaindex.com/industry-news-item/?newsId=8061860655709348
Canopy Growth Corporation to announce third quarter fiscal 2018 financial results
https://www.theglobeandmail.com/investing/markets/stocks/WEED-T/pressreleases/1293879/
Its far far far too many posts...IMHO
Order #699825
I am 100% back in. Here is to future growth
I would not be surprised to see it delayed. I am thinking Aug - Sept
Order #686797
looking at this web page it tells you if it is a "buy" or "sell".
How do they tell if is buy or sell? Is it not both?
https://ih.advfn.com/stock-market/TSX/WEED/trades
Order #667556
TD WATERHOUSE DOWN AGAIN TODAY...
I THINK I AM FULLY BACK IN....I HOPE SO
TD STILL HAS ME IN Q FOR 1HR 25 MINS.